Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis

BACKGROUND: Although combination therapy using clarithromycin, rifampicin, and ethambutol is recommended for patients with pulmonary Mycobacterium avium complex (MAC) disease, some patients do not tolerate it because of adverse effects or underlying diseases. The efficacy and safety of fluoroquinolo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Shuto, Hisayuki, Komiya, Kosaku, Goto, Akihiko, Kan, Takamasa, Honjo, Kokoro, Uchida, Sonoe, Takikawa, Shuichi, Yoshimatsu, Tetsuyuki, Yamasue, Mari, Hiramatsu, Kazufumi, Kadota, Jun-ichi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347193/
https://ncbi.nlm.nih.gov/pubmed/32645105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0235797
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge